Cargando…

Precision intervention of cell type-specific targeting is required for future cancer immunotherapy

Detalles Bibliográficos
Autores principales:	Cai, Yitong, Zhang, Anli, Lu, Changzheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2023
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471107/ https://www.ncbi.nlm.nih.gov/pubmed/37724260 http://dx.doi.org/10.1515/mr-2022-0037

Ejemplares similares

Precision medicine: the foundation of future cancer therapeutics
por: Shin, Seung Ho, et al.
Publicado: (2017)

Two contrasting papers stimulate a commentary on the origins of tumour immunology, current cancer immunotherapies, and the future potential for cancer immunotherapy
por: Bodmer, Walter
Publicado: (2022)

Targeting diagnostic interventions for oesophageal cancer
por: Hamilton, Willie, et al.
Publicado: (2023)

T-cell tumour exclusion and immunotherapy resistance: a role for CAF targeting
por: Hanley, Christopher J., et al.
Publicado: (2020)

Precision radiogenomics: fusion biopsies to target tumour habitats in vivo
por: Crispin-Ortuzar, Mireia, et al.
Publicado: (2021)

Bioengineering of bacteria for cancer immunotherapy
por: Nguyen, Dinh-Huy, et al.
Publicado: (2023)

Organoid modeling for cancer precision medicine
por: Cantrell, Michael A, et al.
Publicado: (2015)

Potential solutions for manufacture of CAR T cells in cancer immunotherapy
por: Blache, Ulrich, et al.
Publicado: (2022)

New additions to the cancer precision medicine toolkit
por: Mardis, Elaine R.
Publicado: (2018)

Real world evidence of long-term benefits from allergen-specific immunotherapy (AIT)
por: Scadding, Guy
Publicado: (2021)

Cancer immunotherapy comes of age and looks for maturity
por: Finck, Amanda, et al.
Publicado: (2020)

The grace of aging with ART: Ex vivo dendritic cell-based immunotherapy restores HIV-specific functional CD8(+) T-cells
por: Mehraj, Vikram, et al.
Publicado: (2022)

Acquired mechanisms of immune escape in cancer following immunotherapy
por: Bryan Iorgulescu, J., et al.
Publicado: (2018)

Towards evidence-based response criteria for cancer immunotherapy
por: Garralda, Elena, et al.
Publicado: (2023)

T follicular helper and B cell crosstalk in tertiary lymphoid structures and cancer immunotherapy
por: Garaud, Soizic, et al.
Publicado: (2022)

COVID-19 vaccination and cancer immunotherapy: should they stick together?
por: Brest, Patrick, et al.
Publicado: (2021)

Precision medicine and the cursed dimensions
por: Barbour, Dennis L.
Publicado: (2019)

Will future microbots be task-specific customized machines or multi-purpose “all in one” vehicles?
por: Wang, Joseph
Publicado: (2021)

The microbiome in precision medicine: the way forward
por: Petrosino, Joseph F.
Publicado: (2018)

Optimising targeted dietary intervention strategies based on regional disparities of the related burden of cardiovascular disease in China
por: Li, Jianxin, et al.
Publicado: (2023)

Precision histology: how deep learning is poised to revitalize histomorphology for personalized cancer care
por: Djuric, Ugljesa, et al.
Publicado: (2017)

The central role of pathology labs in breast cancer precision oncology: a call for action
por: Pruneri, Giancarlo, et al.
Publicado: (2023)

Ferroptosis: a new approach for immunotherapy
por: Zeng, Chong, et al.
Publicado: (2020)

Narrowing the spectrum: the new frontier of precision antimicrobials
por: Paharik, Alexandra E., et al.
Publicado: (2017)

Is precision medicine relevant in the age of COVID-19?
por: Zhou, Amy, et al.
Publicado: (2021)

Working towards precision medicine in developmental programming
por: Giussani, Dino A.
Publicado: (2021)

The importance of external validation to advance precision psychiatry
por: Oliver, Dominic
Publicado: (2022)

Early immunomodulators with CAR T-cell immunotherapy in the COVID-19 era
por: Abid, Muhammad Bilal
Publicado: (2022)

A tool to identify NCD interventions to achieve the SDG target
por: Pickersgill, Sarah J, et al.
Publicado: (2022)

Prostate cancer grading, time to go back to the future
por: Egevad, Lars, et al.
Publicado: (2020)

Immunotherapy in COVID-19: why, who, and when?
por: Sinha, Pratik, et al.
Publicado: (2021)

Can precision medicine get us through menopause?
por: Vieira-Potter, Victoria J.
Publicado: (2022)

PARP inhibition in breast cancer: progress made and future hopes
por: Tung, Nadine, et al.
Publicado: (2022)

Why precision medicine is not the best route to a healthier world
por: Rey-López, Juan Pablo, et al.
Publicado: (2018)

p53 activation: a checkpoint for precision genome editing?
por: Conti, Anastasia, et al.
Publicado: (2018)

Fecal microbiota transplantation in gastrointestinal disorders: time for precision medicine
por: Benech, Nicolas, et al.
Publicado: (2020)

Immunotherapies for COVID-19: lessons learned from sepsis
por: Remy, Kenneth E, et al.
Publicado: (2020)

From macrophage biology to macrophage-based cellular immunotherapies
por: Mass, Elvira, et al.
Publicado: (2021)

Immune-related adverse events and the balancing act of immunotherapy
por: Conroy, Michael, et al.
Publicado: (2022)

Myelination: some receptors required
por: Scherer, Steven S.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_gc31f591uab4vk4613tkka6l46